Want to participate in a research study? Help shape the future of investing tools and earn a $60 gift card!
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shareholders might understandably be very concerned that the share price has dropped 33% in the last quarter. In contrast, the return over three years has been impressive. In fact, the share price is up a full 117% compared to three years ago. It's not uncommon to see a share price retrace a bit, after a big gain. The fundamental business performance will ultimately dictate whether the top is in, or if this is a stellar buying opportunity.
In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.
During three years of share price growth, Vanda Pharmaceuticals moved from a loss to profitability. That kind of transition can be an inflection point that justifies a strong share price gain, just as we have seen here.
You can see how EPS has changed over time in the image below (click on the chart to see the exact values).
It is of course excellent to see how Vanda Pharmaceuticals has grown profits over the years, but the future is more important for shareholders. If you are thinking of buying or selling Vanda Pharmaceuticals stock, you should check out this FREE detailed report on its balance sheet.
A Different Perspective
It's good to see that Vanda Pharmaceuticals has rewarded shareholders with a total shareholder return of 14% in the last twelve months. Since the one-year TSR is better than the five-year TSR (the latter coming in at 7.3% per year), it would seem that the stock's performance has improved in recent times. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. Most investors take the time to check the data on insider transactions. You can click here to see if insiders have been buying or selling.
If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.
We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
If you spot an error that warrants correction, please contact the editor at firstname.lastname@example.org. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.